Clinical Trial Detail

NCT ID NCT03786926
Title Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Indications

Waldenstroem's macroglobulinemia

chronic lymphocytic leukemia

follicular lymphoma

mantle cell lymphoma

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

CLL/SLL

Therapies

HMPL-689

Age Groups: adult senior

No variant requirements are available.